Sean P. David, MD is a Family Medicine Physician - General practicing in Skokie, IL
He has not yet shared a personalized biography with Doctor.com.
University | Degree | Focus | Graduated |
---|---|---|---|
University of Wa School of Medicine, Seattle Wa | Other Degree | 1995 | |
University of Washington School of Medicine, Seattle | Medical Degree | 1995 | |
University of Washington School of Medicine | Medical Degree | 1995 |
Institution | Focus | Year |
---|---|---|
Residency - Dartmouth University | 1998 | |
Residency - Mary Hitchcock Mem Hospital, Family Medicine; Concord Hospital, Family Medicine | Not Specified | |
Internship - Dartmouth University | 1996 |
Certification | Cert. Body | Year |
---|---|---|
Family Medicine | Family Medicine | Not Specified |
Publication | Publisher | Title | Published |
---|---|---|---|
Other Publication | TRENDS IN COGNITIVE SCIENCES | Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention | 2014 |
Other Publication | JAMA : the jourl of the American Medical Association | Clinical interpretation and implications of whole-genome sequencing. | 2014 |
Other Publication | Clinical pharmacology and therapeutics | Association of CHR5-A3 | |
Other Publication | Nicotine & tobacco research : official jourl of the Society for Resear | The Effects of Nicotine Deprivation | |
Other Publication | BMJ open | Systematic review and meta-alysis of opioid antagonists for smoking cessation. | 2014 |
Other Publication | PREVENTIVE MEDICINE | Tobacco dependence treatment teaching by medical school clerkship preceptors | 2013 |
Other Publication | Clinical pharmacology & therapeutics | Biomarkers for smoking cessation. | 2013 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Pharmacogenetic Smoking Cessation Intervention in a Health Care Setting: A Pilot Feasibility Study | 2013 |
Other Publication | PloS one | Potential reporting bias in FMRI studies of the brain. | 2013 |
Other Publication | Human Brain Mapping | Evidence of reporting biases in voxel-based morphometry | |
Other Publication | PHARMACOGENETICS AND GENOMICS | PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2 | 2012 |
Other Publication | GENETIC EPIDEMIOLOGY | Smoking and Genetic Risk Variation Across Populations of European, Asian | 2012 |
Other Publication | TRANSLATIOL PSYCHIATRY | Genome-wide meta-alyses of smoking behaviors in African Americans | 2012 |
Other Publication | PSYCHIATRY RESEARCH-NEUROIMAGING | The neuroeconomics of nicotine dependence | 2012 |
Other Publication | ANLS OF BEHAVIORAL MEDICINE | Relationship Between Amounts of Daily Cigarette Consumption | 2012 |
Other Publication | PLOS GENETICS | Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence | 2011 |
Other Publication | ADDICTION | Associations of CYP2A6 genotype with smoking behaviors in southern Chi | 2011 |
Other Publication | PHARMACOGENOMICS | Genome-wide association for smoking cessation success | 2010 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Sex differences in TTC12 | 2010 |
Other Publication | DRUG AND ALCOHOL DEPENDENCE | Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy | 2008 |
Other Publication | PHARMACOGENOMICS | Genetic variation in the dopamine pathway and smoking cessation | 2008 |
Other Publication | ARCHIVES OF GENERAL PSYCHIATRY | Molecular genetics of successful smoking cessation - Convergent genome | 2008 |
Other Publication | BRITISH MEDICAL JOURL | Smoking cessation in primary care | 2008 |
Other Publication | PHARMACOGENOMICS JOURL | Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation | 2008 |
Other Publication | BMJ (Clinical research ed.) | Smoking cessation. | 2008 |
Other Publication | Contemporary clinical trials | Teaching tobacco dependence treatment and counseling skills during medical school | 2014 |
Other Publication | ADDICTION | Commentary on Chen et al. (2014) | 2014 |
Other Publication | Addiction | Influence of a dopamine pathway additive genetic efficacy score on smoking cessation | 2013 |
Other Publication | JOURL OF THE AMERICAN BOARD OF FAMILY MEDICINE | Communities of Solution: Partnerships for Population Health | 2013 |
Other Publication | Mallick, A., Bergen, A., Nishita, D., Wei, X., Michel, M., David, S. P | CHRONIC STRESS & SALIVARY BIOMARKERS | 2013 |
Other Publication | JOURL OF HUMAN HYPERTENSION | Association between daily cigarette consumption | 2013 |
Other Publication | Menopause (New York, N.Y.) | No association between germline variation in catechol-O-methyltransferase | |
Other Publication | American family physician | Improving America's health requires community-level solutions: Folsom revisited. | |
Other Publication | PSYCHONEUROENDOCRINOLOGY | Chronic psychosocial stressors and salivary biomarkers in emerging adults | 2012 |
Other Publication | ANLS OF FAMILY MEDICINE | Communities of Solution: The Folsom Report Revisited | 2012 |
Other Publication | PHARMACOGENOMICS JOURL | Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation | 2012 |
Other Publication | DRUG AND ALCOHOL DEPENDENCE | Association between CHR5 genetic variation at rs16969968 | 2012 |
Other Publication | EUROPEAN JOURL OF ENDOCRINOLOGY | Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways | 2011 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Pharmacogenetics of Smoking Cessation in General Practice | 2011 |
Other Publication | PSYCHIATRY RESEARCH-NEUROIMAGING | Effects of nicotine withdrawal on verbal working memory and associated brain response | 2010 |
Other Publication | In: Brain Imaging in Behavioral Medicine and Neuropsychology. Edited b | Application of Functiol Neuroimaging Methods to Nicotine Dependence. | |
Other Publication | Clin Pharmacol Ther. | Dopamine Transporters: Chemistry, Biology, and Pharmacology. | 2009 |
Other Publication | Am J Lifestyle Med. | Lifestyle Medicine by Gary Egger, Andrew Binns, and Stephen Rossner. | 2009 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Association of the DRD2 gene Taq1A polymorphism and smoking behavior: A meta-alysis and new data | 2009 |
Other Publication | Praxis | [Smoking cessation]. | 2008 |
Other Publication | NICOTINE & TOBACCO RESEARCH | A cost-effectiveness alysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment | 2008 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults | 2008 |
Other Publication | AMERICAN JOURL OF PUBLIC HEALTH | Successful Latino community partnership program for smoking cessation | 2007 |
Other Publication | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | Association of COMT Val(108 | 2007 |
Other Publication | NICOTINE & TOBACCO RESEARCH | The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch | 2007 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation | 2007 |
Other Publication | Brain imaging and behavior | Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum | 2007 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism | 2007 |
Other Publication | Medicine and health, Rhode Island | Building a successful research enterprise in family medicine: the Brown experience. | 2006 |
Other Publication | Medicine and health, Rhode Island | Fellowship training in family medicine at Brown: adding depth to breadth. | 2006 |
Other Publication | Doctoral thesis: University of Oxford, Bodleian Library, Oxford, UK. | Studies of Genetic Influences on Nicotine Dependence Utilising Functiol Neuroimaging. | |
Other Publication | COCHRANE DATABASE OF SYSTEMATIC REVIEWS | Opioid antagonists for smoking cessation | |
Other Publication | Chapter 21 in: Pharmacogenomics and Proteomics: Ebling the Practice of | The Pharmacogenetics of Nicotine Addiction and Smoking Cessation. | 2006 |
Other Publication | BIOLOGICAL PSYCHIATRY | Ventral striatum/nucleus accumbens activation to smoking | 2005 |
Other Publication | JOURL OF NEUROSCIENCE | A functiol genetic variation of the serotonin | 2005 |
Other Publication | Medicine and health, Rhode Island | Envisaging and applying a unifying three-dimensiol theoretical framework for generalist physicians. | 2004 |
Other Publication | GENETICS IN MEDICINE | Does providing hereditary breast cancer risk assessment support to practicing physicians decrease | 2004 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Investigating subgroups in smoking cessation treatment response: Response to Perkins | 2004 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-alysis | 2004 |
Other Publication | PRIMARY CARE | Pharmacogenetics | 2004 |
Other Publication | ABSAME | Evaluation of an educatiol intervention for medical students to promote competency in social | 2004 |
Other Publication | Nicotine Tob Res | Investigating subgroups in smoking cessation treatment response: Response to Perkins. | 2004 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for | 2003 |
Other Publication | AMERICAN FAMILY PHYSICIAN | Should we offer routine breast cancer screening with mammography? | 2003 |
Other Publication | FAMILY MEDICINE | Genetic susceptibility to breast cancer: Teaching points | 2003 |
Other Publication | NICOTINE & TOBACCO RESEARCH | Comment on The public health implications of smoking-induced decreased serum | 2003 |
Other Publication | FAMILY MEDICINE | Are family physicians willing to use pharmacogenetics for smoking cessation therapy? | 2003 |
Other Publication | American family physician | Should we prescribe antibiotics for acute conjunctivitis? | 2002 |
Other Publication | AMERICAN FAMILY PHYSICIAN | Should we use multiple risk factor interventions for the primary prevention of corory heart dise | 2002 |
Other Publication | PHARMACOGENETICS | No association between functiol catechol O-methyl transferase 1947A > G polymorphism | 2002 |
Other Publication | AMERICAN FAMILY PHYSICIAN | Should we recommend nicotine replacement therapy? | 2001 |
Other Publication | FAMILY PRACTICE | A civic role for physicians in the promotion of global tobacco control | 2001 |
Other Publication | ANLS OF INTERL MEDICINE | Social marketing: Application to medical education | 2001 |
Other Publication | Cochrane database of systematic reviews | Opioid antagonists for smoking cessation. | 2001 |
Other Publication | Prim Care Rep. | Smoking cessation for the primary care physician. | 2001 |
Other Publication | FAMILY MEDICINE | Media advocacy for the office-based teacher of family medicine | 2001 |
Other Publication | JOURL OF PUBLIC HEALTH POLICY | Intertiol tobacco control: A focus group study of US anti-tobacco activists | 2001 |
Other Publication | FAMILY MEDICINE | Reflections from a rotation in Cambridge, England | 2000 |
Other Publication | Jourl of cancer education | The Transatlantic Conference on Tobacco (TACT): a model for intertiol tobacco policy activism. | 1998 |
Family Practice
Years In Practice: 23 (started in 2002)
Accepts New Patients: Yes
Sean P. David, MD has not yet listed the medications that he commonly prescribes.